Page 2 - Russell Rosenberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Incannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep Apnoea

Incannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep Apnoea
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRussell rosenbergLimitedmr joel lathammanagingJohn douglas hudsonAustralian stock exchangeIncannex healthcare limited nasdaqUnited states alyssa factor edison groupOhio state universityIncannex healthcareNeurotrials research in atlantaDrug administrationLuke medical centerContinuous positive airway pressureHealthcare limitedInvestigational new drugAdministrative information

Should I buy Incannex shares while they re at multi-year lows, or steer clear?

Should I buy Incannex shares while they re at multi-year lows, or steer clear?
fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.

John hudsonRussell rosenbergIncannex healthcare ltd

Incannex Healthcare Ltd appoints principal investigators for pivotal IHL-42X trial

Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) CEO Joel Latham tells Proactive the company has appointed two highly experienced lead principal investigators.

United statesJohnd hudsonRussell rosenbergJoel lathamNeurotrials research inc in atlantaIncannex healthcare ltdFuturesearch trialsNeurotrials research incInstitutional review

Market wrap: risk on sentiment sparks bullish surge

The Australian market had one of its best days this year on Friday, rising 1.1% as it chased the US market which reached a 14-month high.

Golden mileJames bayCanada generalWestern australiaNew zealandMichele bullockRoy morganJerome powellDamon dormerThomas reddicliffeRussell rosenbergChristopher kentJohn hudsonFederal reserveNational australia bankBank board

Incannex Enlists Investigators for Study of IHL-42X for Sleep Apnea

Incannex Healthcare recruited two lead principal investigators for a phase 2/3 clinical trial investigating IHL-42X for the treatment of OSA.

United statesRussell rosenbergJohnd hudsonJoel lathamNational sleep foundationNeurotrials researchAmerican academy of sleep medicineDrug administrationNeurotrials research incIncannex healthcare ltdInvestigational new drugFuturesearch trialsInstitutional reviewSearch trialsAmerican academyToday show